Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model
収録刊行物
-
- J Cardiovasc Pharmacol
-
J Cardiovasc Pharmacol 23 674-680, 1994